President Donald Trump has said generic drug manufacturers must move production to the United States or face a 100% import tariff from August 2028, with the levy set to rise to 200% in August 2029. The proposal is aimed at bringing more generic pharmaceutical manufacturing onshore, but it could pla…
Vertex Pharmaceuticals NASDAQ:VRTX has agreed to buy Crinetics Pharmaceuticals NASDAQ:CRNX for about $10 billion, expanding its reach beyond blood disorders and pain into rare endocrine diseases.The move adds to a growing list of high-profile transactions over the past decade by U.S. pharmaceutical…
Viatris Inc NASDAQ:VTRS:
Viatris entered into an amended and restated term loan credit agreement for a ¥40,000,000,000 senior unsecured term loan. Proceeds will be used for general corporate purposes, including repayment of its prior 2021 ¥40,000,000,000 facility. The loan initially bears interest at the TIBO rate plus 1.1…
PITTSBURGH, July 1, 2026 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced it will report second-quarter 2026 financial results on Thursday, August 6, 2026. Company executives will host a conference call and live webcast at 8:30 a.m. ET on the same date to di…
